We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > glucocorticoid

News List

Methylprednisolone API Manufacturers in China PharmaSources
June 04, 2021
Methylprednisolone is a glucocorticoid that is used for treating conditions like arthritis, renal diseases, certain allergic reactions, and immune system diseases and disorders. It works by minimizing the immune system’s response to various threats
Postoperative Infection Rate Similar Across Biologics in RA drugs
May 21, 2019
Postoperative Infection Rate Similar Across Biologics in RA.
Denosumab reduces glucocorticoid-induced bone loss europeanpharmaceuticalreview
May 02, 2018
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients…
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis biospace
April 28, 2018
Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorization of Prolia® for the treatment of bone loss associated with long-term systemic